Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S0WX
|
||||
Former ID |
DNC010211
|
||||
Drug Name |
9-(2-aminopropyl)-9,10-dihydroanthracene
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530331] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H19N
|
||||
Canonical SMILES |
C1C2=CC=CC=C2C(C3=CC=CC=C31)CCCN
|
||||
InChI |
1S/C17H19N/c18-11-5-10-17-15-8-3-1-6-13(15)12-14-7-2-4-9-16(14)17/h1-4,6-9,17H,5,10-12,18H2
|
||||
InChIKey |
AUTKMGMMFJXIDV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H1 receptor | Target Info | Inhibitor | [530331] | |
5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [530331] | ||
WikiPathways | Monoamine GPCRs | ||||
GPCRs, Class A Rhodopsin-like | |||||
IL-4 Signaling Pathway | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP733:Serotonin Receptor 2 and STAT3 Signaling | |||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
SIDS Susceptibility Pathways | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.